Donald M. Earhart

GISH Biomedical, Inc. designs, manufactures and markets innovative disposable medical devices for cardiovascular surgery, with a focus on the Perfusionist. The GISH product portfolio also includes targeted solutions for vascular access and orthopedics. All GISH products are single use disposable products or have a disposable component. The company's principal products include oxygenators and oxygenator systems, blood reservoirs, cardioplegia delivery systems, custom cardiovascular tubing systems, central venous access catheters and ports, and blood recovery devices for post-operative use in orthopedic surgeries. With a manufacturing facility and offices in Rancho Santa Margarita, California, GISH markets its products worldwide through a combination of direct sales representatives and specialty medical distributors. GISH has been at the forefront of the design and manufacturing of hospital based and operating room medical devices for over 25 years. From simple sets to complex circuits for open heart surgery, precision and quality in manufacturing is what you can rely on from GISH.

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.

Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology.

Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Part of Cybex International, Inc., Tectrix Fitness Equipment, Inc. makes cardiovascular fitness equipment. The company is based in Irvine, CA. Tectrix Fitness Equipment was acquired by Cybex International, Inc. on May 22, 1998 for $30 million.

DAFNA Capital Management LLC (DAFNA Capital) is a registered investment advisor and hedge fund manager headquartered in Los Angeles, California. The firm was founded by Nathan Fischel in1999 and is a subsidiary of DAFNA Holdings LP. DAFNA Capital provides investment advisory services with respect to one or more private investment funds.

ROTH Capital Partners LLC (Asset Management) (ROTH AM) is the investment management division of ROTH Capital Partners LLC, a registered investment advisor and broker-dealer headquartered in Newport Beach, California. Founded in 1984, the firm is a subsidiary of CR Financial Holdings LLC. ROTH AM is a full-service investment banking firm that provides financing and advisory services to emerging growth companies worldwide.

Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialization expertise. Their focus is on specialist pharmaceuticals with core products in Oncology and diseases of the central nervous system (CNS). They have a proven track record in the development, global registration, marketing, sales and distribution of both innovative and well established pharmaceutical products. This combined with its strong product portfolio and their ability to forge lasting relationships with global partners, has helped them generate substantial sales growth over the past 13 years. They are proud of its independence and entrepreneurial culture. Equally, their strong balance sheet and freedom from debt give them a solid foundation from which they continue to enhance its growth. Cambridge Laboratories is an independent and privately owned company, founded in 1987 and purchased outright by members of the current Board of Directors in 1996.

Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ.

Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.

Regenesis Bioremediation Products, Inc. develops and sells chemical oxidation reagents. Its pRoducts include PlumeStop, Oxygen Release Compund, 3-D Microemulsion, Hydrogen Release Compound, Chemical Reducing Solution, Bio-Dechlor Inoculum, PersulfOx, RegenOx, and PetroCleanze. The firm also offers remediation solutions that include in situ sorption and biodegradation, in situ chemical oxidation, enhanced aerobic biodegradation, enhanced anaerobic bioremediation, bioaugmentation, metal immobilization, excavation, and vapor intrusion mitigation. The company was founded by Gavin S. Herbert in 1994 and is headquartered in San Clemente, CA.

Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.

Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH.

Pavillon International offers addiction treatment and recovery services. The firm’s services include addiction treatment and recovery services such as primary treatment, women's programs, outpatient care, relapse prevention, substance abuse treatment and family care. The company was founded by Liliane Desjardins and Gilles Desjardins in 1996 and is headquartered in Mill Spring, NC.

OCTANe connects people and ideas with capital and resources for technology growth in Orange County. It stimulates technology job growth and wealth creation; helps entrepreneurs turn ideas into successful businesses; helps companies connect with funding and growth resources; helps senior executives access intelligence, new technologies, and talent; helps develop technology business leaders; and creates a forum for technology company leaders to have an impact on the future. The company offers LaunchPad, a pro-bono accelerator for startup companies in the technology, life science, and clean tech industries. The company was founded in 2002 and is headquartered in Aliso Viejo, CA.

Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway.

Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada.

Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA.

Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.